TGFB1 and schizophrenia: There are no data on the impact of combinations of antipsychotics in TRS patients on other cytokines, e.g., IL-2, IL-4, IL-5, IL-10, IL-12, IL-17, IL-23 and TGF-β1, although their involvement in schizophrenia pathophysiology has been demonstrated [58,60].